Related references
Note: Only part of the references are listed.Interleukin-10 levels in rat models of nerve damage and neuropathic pain
Junad Khan et al.
NEUROSCIENCE LETTERS (2015)
PEG-Peptide Conjugates
Ian W. Hamley
BIOMACROMOLECULES (2014)
A Dual-Responsive Mesoporous Silica Nanoparticle for Tumor-Triggered Targeting Drug Delivery
Dong Xiao et al.
SMALL (2014)
Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord
Ellen C. Dengler et al.
JOURNAL OF CONTROLLED RELEASE (2013)
THE ERYTHROPOIETIN-DERIVED PEPTIDE ARA290 REVERSES MECHANICAL ALLODYNIA IN THE NEURITIS MODEL
K. G. T. Pulman et al.
NEUROSCIENCE (2013)
Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns
Stefan Bohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
General Route to Multifunctional Uniform Yolk/Mesoporous Silica Shell Nanocapsules: A Platform for Simultaneous Cancer-Targeted Imaging and Magnetically Guided Drug Delivery
Lingyu Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications
Jonathan O. Martinez et al.
CHINESE SCIENCE BULLETIN (2012)
B7-H3 Participates in the Development of Experimental Pneumococcal Meningitis by Augmentation of the Inflammatory Response via a TLR2-Dependent Mechanism
Xuqin Chen et al.
JOURNAL OF IMMUNOLOGY (2012)
Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain
S. Rose et al.
TRANSLATIONAL PSYCHIATRY (2012)
ARA290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-term Relief of Neuropathic Pain An Experimental Study in Rats and β-Common Receptor Knockout Mice
Maarten Swartjes et al.
ANESTHESIOLOGY (2011)
A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance
Qianjun He et al.
BIOMATERIALS (2011)
Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2Akita) diabetic mouse sympathetic ganglia
Robert E. Schmidt et al.
EXPERIMENTAL NEUROLOGY (2011)
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Michael Costigan et al.
Annual Review of Neuroscience (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
Maria Salazar et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers
Igor I. Slowing et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Dendrimer-Drug Conjugates for Tailored Intracellular Drug Release Based on Glutathione Levels
Raghavendra S. Navath et al.
BIOCONJUGATE CHEMISTRY (2008)
Cytokine mechanisms of central sensitization:: Distinct and overlapping role of interleukin-1β, interleukin-6, and tumor necrosis factor-β in regulating synaptic and neuronal activity in the superficial spinal cord
Yasuhiko Kawasaki et al.
JOURNAL OF NEUROSCIENCE (2008)
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications
Ennio Tasciotti et al.
NATURE NANOTECHNOLOGY (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Perinatal delta-9-tetrahydrocannabinol field behavior in exposure disrupts social and open adult male rats
R. J. Newsom et al.
NEUROTOXICOLOGY AND TERATOLOGY (2008)
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Robert H. Dworkin et al.
PAIN (2007)
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Nitin Agarwal et al.
NATURE NEUROSCIENCE (2007)
Mesoporous materials for drug delivery
Maria Vallet-Regi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
Andrea D. Furlan et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
H Breivik et al.
EUROPEAN JOURNAL OF PAIN (2006)
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
E Eljaschewitsch et al.
NEURON (2006)
Mesoporous silicon microparticles for oral drug delivery:: Loading and release of five model drugs
J Salonen et al.
JOURNAL OF CONTROLLED RELEASE (2005)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Human brain mechanisms of pain perception and regulation in health and disease
AV Apkarian et al.
EUROPEAN JOURNAL OF PAIN (2005)
Role of the immune system in chronic pain
F Marchand et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons
EJ Downer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules
CY Lai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Oral opioid therapy for chronic peripheral and central neuropathic pain
MC Rowbotham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
